Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 1697Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Clinical Pharmacology Studies in Critically Ill Children
Nilay Thakkar,Sara Salerno,Christoph P. Hornik,Daniel Gonzalez
Pharmaceutical Research.2017;34(1)7
2Cultural, geographical and ethical questions when looking to enroll pediatric patients in rare disease clinical trials
Stefan Anzelewicz,Hanna Garnier,Arun Rangaswami,Piotr Czauderna
Expert Opinion on Orphan Drugs.2017;5(8)613
3Cultural, geographical and ethical questions when looking to enroll pediatric patients in rare disease clinical trials
Edel Mc Glanaghy,Nina Di Pietro,Benjamin Wilfond
Expert Opinion on Orphan Drugs.2015;5(8)91
4Cultural, geographical and ethical questions when looking to enroll pediatric patients in rare disease clinical trials
Brian Smith,Alyse Ley,Katherine Krive,Jed Magen
Expert Opinion on Orphan Drugs.2019;5(8)69
5In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant
Simon D. van Haren,Lakshmi Ganapathi,Ilana Bergelson,David J. Dowling,Michaela Banks,Ronald C. Samuels,Steven G. Reed,Jason D. Marshall,Ofer Levy
6Nanomedicines for Pediatric Cancers
Carlos Rodríguez-Nogales,Yolanda González-Fernández,Azucena Aldaz,Patrick Couvreur,María J. Blanco-Prieto
ACS Nano.2018;12(8)7482
7Nanomedicines for Pediatric Cancers
Simon Woods
ACS Nano.2018;12(8)1
8Clinical trials: Kids are not just little people
Fludiona Naka,Bruce Strober,Mona Shahriari
Clinics in Dermatology.2017;35(6)583
9How to Conduct Clinical Trials in Children: A Tutorial
Valentina Shakhnovich,Christoph P. Hornik,Gregory L. Kearns,Jaylene Weigel,Susan M. Abdel-Rahman
Clinical and Translational Science.2019;12(3)218
10Clinical trials in children
Pathma D. Joseph,Jonathan C. Craig,Patrina H.Y. Caldwell
British Journal of Clinical Pharmacology.2015;79(3)357
11Implementation of a Plan–Do–Study–Act framework to reduce unindicated surgical antimicrobial prophylaxis
Mark Kashtan,Michele Dawson,Seema Anandalwar,Jonathan Hills-Dunlap,Dionne A. Graham,Shawn Rangel
Journal of Pediatric Surgery.2020;55(1)86
12Optimizing interim analysis timing for Bayesian adaptive commensurate designs
Xiao Wu,Yi Xu,Bradley P. Carlin
Statistics in Medicine.2020;39(4)424
13A Bayesian approach in design and analysis of pediatric cancer clinical trials
Jingjing Ye,Gregory Reaman,R. Angelo De Claro,Rajeshwari Sridhara
Pharmaceutical Statistics.2020;39(4)424
14Long-Term Treatment Strategies of Pediatric Multiple Sclerosis, Including the use of Disease Modifying Therapies
Mary Rensel
15Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities
Jean C. Dinh,Chelsea M. Hosey-Cojocari,Bridgette L. Jones
Pediatric Drugs.2020;22(1)55
16Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities
Mariana Salles La Terza Velleca
Pediatric Drugs.2014;22(1)196
17Enhancing the Pediatric Drug Development Framework to Deliver Better Pediatric Therapies Tomorrow
Christina Bucci-Rechtweg
Clinical Therapeutics.2017;39(10)1920
18The Current Status of European and National Financial Sources for Clinical Research and Their Impact on Paediatric Non-commercial Clinical Trials: A Case Study of the Czech Republic
L. Horavova,K. Nebeska,L. Souckova,R. Demlova,P. Babula
Therapeutic Innovation & Regulatory Science.2020;39(10)1920
19Experimental Therapeutic Trial Design for Pediatric Brain Tumors
Miriam Bornhorst,Eugene I. Hwang
Journal of Child Neurology.2016;31(12)1421
20Experimental Therapeutic Trial Design for Pediatric Brain Tumors
Christine R. Totri,Lawrence F. Eichenfield
Journal of Child Neurology.2015;31(12)161
21Parents’ attitudes towards and perceptions of involving minors in medical research from the Japanese perspective
Yasue Fukuda,Koji Fukuda
BMC Medical Ethics.2018;19(1)161
22From tokenism to meaningful engagement: best practices in patient involvement in an EU project
David Supple,Amanda Roberts,Val Hudson,Sarah Masefield,Neil Fitch,Malayka Rahmen,Breda Flood,Willem de Boer,Pippa Powell,Scott Wagers
Research Involvement and Engagement.2015;1(1)161
23Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis
Marisa McGinley,Ian T. Rossman
24Effective and safe pharmacotherapy for pediatric population: a call for academia to conduct clinical research
Melva Louisa
Medical Journal of Indonesia.2018;27(4)221
25Medicines for Pediatric Patients—Biopharmaceutical, Developmental, and Regulatory Considerations
David P. Elder,René Holm,Martin Kuentz
Journal of Pharmaceutical Sciences.2017;106(4)950
26Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials
Mary A. Ott,Francis P. Crawley,Xavier Sáez-Llorens,Seth Owusu-Agyei,David Neubauer,Gary Dubin,Tatjana Poplazarova,Norman Begg,Susan L. Rosenthal
Pediatric Drugs.2018;20(3)215
27Pediatric Clinical Trials Conducted in South Korea from 2006 to 2015: An Analysis of the South Korean Clinical Research Information Service, US ClinicalTrials.gov and European Clinical Trials Registries
Sheung-Nyoung Choi,Ji-Hyun Lee,In-Kyung Song,Eun-Hee Kim,Jin-Tae Kim,Hee-Soo Kim
Pediatric Drugs.2017;19(6)569
28Pediatric Trials Run in India: An Analysis of Clinical Trials.gov 2006–2015
Giulia Lorenzoni,Rosanna Irene Comoretto,Mariangela Ruffolo,Danila Azzolina,Ileana Baldi
The Indian Journal of Pediatrics.2019;86(S1)10
29Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors
Miriam Bornhorst,Eugene I. Hwang
Pediatric Drugs.2020;22(1)45

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal